Published in Int Urol Nephrol on September 07, 2012
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant (2013) 1.21
APOL1 kidney risk alleles: population genetics and disease associations. Adv Chronic Kidney Dis (2014) 1.18
Nephrology in Africa--not yet uhuru. Nat Rev Nephrol (2013) 0.94
Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges. Public Health Genomics (2015) 0.93
The influence of HIV and schistosomiasis on renal function: a cross-sectional study among children at a hospital in Tanzania. PLoS Negl Trop Dis (2015) 0.83
Stroke genomics in people of African ancestry: charting new paths. Cardiovasc J Afr (2015) 0.81
Paediatric end-stage renal disease in a tertiary hospital in South West Nigeria. BMC Nephrol (2014) 0.80
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes. PLoS One (2016) 0.80
The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects. Pediatr Nephrol (2013) 0.78
APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans. BMC Genet (2015) 0.77
Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations. Front Endocrinol (Lausanne) (2016) 0.75
Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis. BMC Nephrol (2015) 0.75
Risk of ESRD in the United States. Am J Kidney Dis (2016) 0.75
Recruitment of Yoruba families from Nigeria for genetic research: experience from a multisite keloid study. BMC Med Ethics (2014) 0.75
Kidney disease among children in sub-Saharan Africa: systematic review. Pediatr Res (2014) 0.75
APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke. Acta Neurol Scand (2017) 0.75
Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men. J Neurol Sci (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics (1985) 20.92
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics (1995) 11.58
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet (2010) 5.68
The prevalence of hypertension in seven populations of west African origin. Am J Public Health (1997) 5.55
Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet (2002) 4.29
The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol (2010) 3.15
Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med (1991) 2.74
The origin of malignant malaria. Proc Natl Acad Sci U S A (2009) 2.67
The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34
A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int (2010) 2.22
The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis (1993) 2.22
African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet (2010) 2.11
Obesity and hypertension prevalence in populations of African origin. The Investigators of the International Collaborative Study on Hypertension in Blacks. Epidemiology (1996) 1.91
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol (2009) 1.80
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
Genetics of kidney failure and the evolving story of APOL1. J Clin Invest (2011) 1.69
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol (2011) 1.67
Leptin and body composition of Nigerians, Jamaicans, and US blacks. Am J Clin Nutr (1998) 1.52
Prevalence of NIDDM among populations of the African diaspora. Diabetes Care (1997) 1.36
Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis (1996) 1.24
Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One (2010) 1.14
Evaluation of an electronic blood pressure device for epidemiological studies. Blood Press Monit (1997) 1.09
Chronic kidney disease and life course socioeconomic status: a review. Adv Chronic Kidney Dis (2005) 1.08
Target organ damage in African American hypertension: role of APOL1. Curr Hypertens Rep (2012) 1.02
Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J (1997) 1.00
Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis (2002) 0.88
Arrest of the true culprit and acquittal of the innocent? Genetic revelations charge APOL1 variants with kidney disease susceptibility. Int Urol Nephrol (2010) 0.82
Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet (2007) 14.99
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol (2004) 9.43
Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA (2003) 9.06
Grand challenges in global mental health. Nature (2011) 8.40
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12
A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet (2006) 7.89
Admixture mapping for hypertension loci with genome-scan markers. Nat Genet (2005) 6.78
Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension (2003) 5.63
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47
Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89
Physical activity does not influence obesity risk: time to clarify the public health message. Int J Epidemiol (2013) 4.71
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol (2008) 4.14
Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res (2002) 3.95
Association mapping, using a mixture model for complex traits. Genet Epidemiol (2002) 3.95
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2009) 3.74
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int (2012) 3.46
From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A (2008) 3.39
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11
Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet (2011) 3.07
Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension (2005) 3.07
A unified association analysis approach for family and unrelated samples correcting for stratification. Am J Hum Genet (2008) 3.00
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol (2009) 2.87
A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. Am J Hypertens (2003) 2.76
Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol (2008) 2.74
Neighborhood characteristics and hypertension. Epidemiology (2008) 2.70
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res (2006) 2.59
The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet (2007) 2.35
Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet (2006) 2.34
Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol. Am J Hum Genet (2007) 2.28
Linkage analysis of a complex disease through use of admixed populations. Am J Hum Genet (2004) 2.21
Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension (2007) 2.17
Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int (2004) 2.00
Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol (2010) 1.99
Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem (2003) 1.97
Mapping Africa's way into prominence in the field of neurology. Arch Neurol (2007) 1.97
Genetics. The science and business of genetic ancestry testing. Science (2007) 1.95
Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis (2008) 1.91
Genome-wide association of anthropometric traits in African- and African-derived populations. Hum Mol Genet (2010) 1.90
Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol (2010) 1.89
Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol (2011) 1.87
A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet (2002) 1.87
Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol (2007) 1.87
Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol (2007) 1.84
Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation (2005) 1.84
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Functional disability in elderly Nigerians: Results from the Ibadan Study of Aging. J Am Geriatr Soc (2006) 1.82
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol (2008) 1.79
Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med (2013) 1.78
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet (2011) 1.77
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67
Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens (2006) 1.64
Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis (2010) 1.64
Adverse renal consequences of obesity. Am J Physiol Renal Physiol (2008) 1.62
Association between blood pressure and resting energy expenditure independent of body size. Hypertension (2004) 1.62
Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet (2011) 1.60
Crossing the omic chasm: a time for omic ancillary systems. JAMA (2013) 1.59
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Race and ancestry in biomedical research: exploring the challenges. Genome Med (2009) 1.55
Combined admixture mapping and association analysis identifies a novel blood pressure genetic locus on 5p13: contributions from the CARe consortium. Hum Mol Genet (2011) 1.54
The Nigerian antihypertensive adherence trial: a community-based randomized trial. J Hypertens (2013) 1.52
Interrogating local population structure for fine mapping in genome-wide association studies. Bioinformatics (2010) 1.48
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet (2011) 1.47
Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest (2014) 1.46
Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur J Hum Genet (2008) 1.45
An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population. J Hypertens (2003) 1.44
Assessing physical activity and its relationship to cardiovascular risk factors: NHANES 2003-2006. BMC Public Health (2011) 1.44
Adjustment for local ancestry in genetic association analysis of admixed populations. Bioinformatics (2010) 1.44
Acculturation is associated with hypertension in a multiethnic sample. Am J Hypertens (2007) 1.43
Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis. Am J Hypertens (2009) 1.41
Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk. BMC Public Health (2011) 1.39
Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PLoS One (2009) 1.39
Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. J Clin Endocrinol Metab (2013) 1.39
Predicting incident diabetes in Jamaica: the role of anthropometry. Obes Res (2002) 1.38
APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Ann Neurol (2006) 1.36
Genome-wide comparison of African-ancestry populations from CARe and other cohorts reveals signals of natural selection. Am J Hum Genet (2011) 1.35
Voluntary participation and informed consent to international genetic research. Am J Public Health (2006) 1.32
Opportunities for genomic clinical decision support interventions. Genet Med (2013) 1.31
Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J (2011) 1.31
Admixture mapping provides evidence of association of the VNN1 gene with hypertension. PLoS One (2007) 1.31
Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol (2008) 1.31
The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells. Am J Physiol Renal Physiol (2008) 1.31
Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2011) 1.30